AbbVie (ABBV) Return on Invested Capital (2013 - 2026)

AbbVie (ABBV) has 14 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital grew to 0.0% in Q1 2026 per ABBV's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.22% in Q3 2025 and bottomed at 0.0% in Q4 2023.
• The 5-year median for Return on Invested Capital is 0.0% (2026), against an average of 0.02%.
• The widest annual swing landed in 2022, when Return on Invested Capital changed 0 bps; it then grew 21 bps in 2025.
• Tracing ABBV's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then tumbled by 35 bps to 0.0% in 2023, then rose by 26 bps to 0.0% in 2024, then climbed by 18 bps to 0.0% in 2025, then rose by 7 bps to 0.0% in 2026.
• Per Business Quant, the three latest ABBV Return on Invested Capital figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.22% (Q3 2025).

Peer Comparison